MAPT and Alzheimer disease: We previously profiled S-nitrosylation in the CK-p25 mouse model of AD, which exhibits DNA damage, aberrant gene expression, increased amyloid-β levels, and neuronal and synaptic loss followed by cognitive impairment and tau hyperphosphrylation and aggregation at later stages27.